Your Health, We Care
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Anamorelin helps cancer patients with dyscrasia restore the body's energy supply by stimulating appetite and increasing growth hormone secretion. It is currently the only widel···【more】
Article source：Captain MedicineRelease date：2024-08-21Recommended：456
In 2021, Japan approved Anamorelin for the treatment of cachexia caused by various cancers such as non-small cell lung cancer. The drug has performed well in multiple clinical tria···【more】
Article source：Captain MedicineRelease date：2024-08-21Recommended：558
Anamorelin is a novel ghrelin receptor agonist specifically designed for the treatment of cancer cachexia. It provides vital support to patients with advanced cancer by increasing ···【more】
Article source：Captain MedicineRelease date：2024-08-21Recommended：563
Anamorelin is a selective oral medication that increases a patient's appetite and body weight primarily by activating ghrelin receptors. It is especially suitable for cancer pa···【more】
Article source：Captain MedicineRelease date：2024-08-21Recommended：479
Anamorelin is a ghrelin receptor agonist that is effective in improving appetite and muscle mass in patients with cancer cachexia. Drugs have shown good results in clinical trials,···【more】
Article source：Captain MedicineRelease date：2024-08-21Recommended：590
Anamorelin, the world's first oral drug specifically for the treatment of cancer cachexia, was launched by Ono Pharmaceutical of Japan in 2021. It helps patients regain their a···【more】
Article source：Captain MedicineRelease date：2024-08-21Recommended：540
Koselugois a small molecule drug inhibitor targeting the MEK signaling pathway, and its core utility is focused on specific neurofibromas and has demonstrated excellent therapeutic···【more】
Article source：Captain MedicineRelease date：2024-08-21Recommended：475
Koselugois a small molecule inhibitory drug targeting the MEK signaling pathway, and its core efficacy is reflected in its specific effect on specific neurofibromas, by blocking th···【more】
Article source：Captain MedicineRelease date：2024-08-21Recommended：492
Koselugo, as a small molecule blocker of the MEK signaling pathway, has a core effect on specific neurofibromatosis by inhibiting the growth and proliferation mechanism of tumor ce···【more】
Article source：Captain MedicineRelease date：2024-08-21Recommended：538
Koselugo is a small molecule inhibitor targeting the MEK signaling pathway, mainly used to treat specific types of neurofibromatosis, by blocking the growth and proliferation of tu···【more】
Article source：Captain MedicineRelease date：2024-08-21Recommended：518
Koselugo is a small molecule inhibitor targeting MEK, which plays the role of a blocker on the mitogen activation link, and its core efficacy is reflected in the inhibition of MEK ···【more】
Article source：Captain MedicineRelease date：2024-08-21Recommended：470
Koselugo is a small molecule MEK inhibitor and a repressor of mitogen activation, and its core role is to inhibit the activation of MEK signaling pathways, thereby effectively inte···【more】
Article source：Captain MedicineRelease date：2024-08-21Recommended：469
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】
Recommended：8532025-17-12
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended：10502024-09-07
Recently, Lao Lucius Pharmaceutical (Lucius Pharmaceuticals) issued a solemn statement regarding cou···【more】
Recommended：3082026-10-10
Lucius Pharmaceuticals Version of Vibegron Now Available1.Basic Drug InformationVibegron (generic na···【more】
Recommended：4052026-06-08
In recent years, leveraging the World Trade Organization (WTO) patent waiver for least-developed cou···【more】
Recommended：5972026-05-08
How Can Chinese Patients Access Generic Drugs from Laos?In recent years, generic drugs from Laos hav···【more】
Recommended：5692026-04-08
Lucius Pharmaceuticals version of Ibrutinib is now availableIn a randomized controlled trial of 269 ···【more】
Recommended：4552026-03-08
Leveraging the WTO patent waiver for least-developed countries (extended to 2033), Laos has seen rap···【more】
Recommended：6072026-31-07
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address: No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Name: Lucius
Telegram name: Vira
No.:0085253923643
Telegram name: Vira
No.:0085253923643
